Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01983384 · ClinicalTrials.gov registry record · NA

Anesthetic Depth and Postoperative Delirium Trial - 2

A NA study of Delirium and Cognitive Disorders, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
205
Enrollment target
1
Study location

NCT01983384: Completed NA study of Delirium and Cognitive Disorders, sponsored by University of California, San Francisco.

NCT01983384 is a NA study of Delirium and Cognitive Disorders that has completed, run by University of California, San Francisco. The registered enrollment target is 205 participants, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01983384, a NA study of Delirium and Cognitive Disorders, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
205 participants
Enrollment target
1
Study location

Study Summary

Recent limited evidence suggests that anesthetic depth may influence postoperative cognitive outcomes, however, the mechanism between this association is unclear.

Primary Outcome

Intraoperative EEG suppression will be measured by processed EEG monitor

Interventions

  • OTHER Processed EEG-guided anesthetic depth

Study Locations (1)

California

  • University of California, San Francisco Medical Center - San Francisco

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2015-07
Est. Completion 2017-10
Phase NA

What the finished NCT01983384 record still lists

NCT01983384 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 884-participant average among 62 other Delirium trials with a reported enrollment target (77% lower).

The record links to 2 conditions, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which Processed EEG-guided anesthetic depth is the first listed.

NCT01983384 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01983384 about?

NCT01983384 is a clinical study titled "Anesthetic Depth and Postoperative Delirium Trial - 2". Recent limited evidence suggests that anesthetic depth may influence postoperative cognitive outcomes, however, the mechanism between this association is unclear.

What is the current status of trial NCT01983384?

This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2015-07. Estimated completion is 2017-10.

What conditions does trial NCT01983384 study?

This clinical trial studies the following conditions: Delirium, Cognitive Disorders.

What interventions are being tested in trial NCT01983384?

The interventions under investigation include: Processed EEG-guided anesthetic depth (OTHER).

Who is sponsoring clinical trial NCT01983384?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01983384 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01983384's enrollment target sits among peer trials

205 29th of 62 higher than 34 of 62 other Delirium trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03457493 · 205 participants · Phase 1

    The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

  • NCT05134857 · 205 participants · Phase 2

    The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

  • NCT05181891 · 205 participants · Phase 2

    Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

  • NCT05283811 · 205 participants · NA

    Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01983384, the US trial registry maintained by the National Library of Medicine. NCT01983384 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.